General Wellness Products vs. Medical Devices: The Complete Decision Guide

One of the most consequential decisions a health technology company faces is determining whether its product is a regulated medical device or an exempt general wellness product. Get it right, and you can launch quickly with minimal regulatory overhead. Get it wrong, and you risk warning letters, forced recalls, product seizures, and significant reputational damage.

This guide provides a practical, step-by-step framework for making that determination under United States Food and Drug Administration (FDA) rules, with notes on how the European Union framework differs. It is written for founders, product managers, regulatory affairs staff, and anyone bringing a health-adjacent product to market.

Why the Distinction Matters

The FDA's General Wellness: Policy for Low Risk Devices guidance establishes that certain low-risk products intended only to promote general wellness are not regulated as medical devices. This means no premarket notification (510(k)), no premarket approval (PMA), and no establishment registration for device manufacturing.

By contrast, a product that meets the statutory definition of a medical device — anything intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease — falls under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and must comply with applicable device requirements.

The practical difference is enormous. A 510(k) submission typically costs tens of thousands of dollars and takes several months. A PMA can take years and cost millions. Avoiding unnecessary regulation while remaining compliant is therefore a core commercial priority.

The Two-Pronged FDA Test

The FDA's wellness guidance rests on two cumulative criteria. A product qualifies as a general wellness product only if both are satisfied.

Prong 1 — General population, not disease-specific. The product must be intended for use by the general population, or by a subset defined by characteristics such as age or pregnancy — not by a specific disease or condition. A product marketed to "people with type 2 diabetes" fails this prong immediately.

Prong 2 — Healthy lifestyle claims only. The product's claims must relate to maintaining or encouraging a healthy lifestyle and must not reference specific diseases or conditions. Permitted claim categories include:

• Promoting relaxation or stress management
• Encouraging physical activity or fitness
• Improving sleep quality
• Enhancing mental acuity or focus
• Supporting healthy eating or weight management
• Tracking general physiological states (steps, heart rate during exercise)

Critically, the guidance also imposes a safety condition: the product must not pose a risk to human health if it malfunctions or is misused, and it must not involve invasive procedures or technology that could cause harm.

Step-by-Step Decision Framework

Work through these eight steps in order. A "stop" at any stage means you have crossed into medical device territory.

Step 1 — Catalogue every claim. Gather all labelling, packaging, website copy, app store descriptions, advertisements, investor decks, social media posts, and sales scripts. Intended use is determined by the totality of your claims, not just the label. A statement made in a funding pitch can establish intended use.

Step 2 — Screen for disease language. Highlight every reference to a named disease, disorder, condition, symptom, or clinical state. Terms such as "diagnose," "treat," "prevent," "detect," "screen for," "monitor for signs of," and "reduce risk of" are strong indicators of device intent. If any disease-specific claim exists, stop — you are likely a medical device.

Step 3 — Identify the target population. Determine whether your marketing addresses the general population or a disease-defined cohort. "For adults over 50" is acceptable. "For adults with hypertension" is not.

Step 4 — Map claims to the permitted wellness categories. Confirm each remaining claim fits within the FDA's enumerated healthy-lifestyle categories. If a claim falls outside those categories, reassess carefully.

Step 5 — Assess health risk on malfunction. Ask what happens if the product fails, gives inaccurate readings, or is used incorrectly. A step counter that under-counts steps poses negligible risk. A device that advises on medication timing or insulin dosing poses serious risk and cannot qualify as wellness.

Step 6 — Evaluate invasiveness. Any product that penetrates the skin, enters a body orifice, or is implanted is almost certainly a device. Non-invasive sensing is generally compatible with wellness status.

Step 7 — Check the software dimension. Software as a Medical Device (SaMD) follows the same logic. An app that coaches general fitness is wellness. An app that interprets symptoms and suggests a diagnosis is a device. The FDA's Digital Health Center of Excellence maintains guidance on this boundary.

Step 8 — Document your rationale. Record the analysis, the claims reviewed, and the reasoning behind your classification. This contemporaneous documentation is your first line of defence if a regulator questions your position.

Common Failure Points

Three recurring mistakes push wellness products into device territory.

Marketing drift. Product teams add persuasive claims over time without regulatory review. A single phrase — "helps detect irregular heartbeats" — can reclassify an entire product line.

Feature creep. Adding a clinically meaningful algorithm to an existing wellness device changes its intended use, even if the hardware is unchanged.

Ambiguous language. Phrases like "clinically proven," "medical-grade," or "diagnostic accuracy" imply medical intent even without naming a disease. Avoid them unless you are prepared to regulate accordingly.

How the EU Differs

The EU does not recognise a "general wellness" exemption. Under Regulation (EU) 2017/745 (MDR), a product is a medical device if the manufacturer intends it for a medical purpose, as stated in Article 2(1). There is no intermediate wellness category.

Instead, the EU relies on the absence of medical intent. If your product makes no medical claims, it simply falls outside the MDR's scope — but the burden of demonstrating that rests entirely on the manufacturer. Products that were Class I under the former Medical Device Directive (MDD) often moved to Class IIa or higher under the MDR, particularly where software or measurement functions are involved.

Practical consequence: a product comfortably classified as wellness in the US may still attract scrutiny in Europe if its claims are ambiguous. Conservative claim drafting is advisable for any product sold in both markets.

Practical Recommendations

Adopt a claim-review gate in your product development process. No public-facing statement about health benefit should ship without regulatory sign-off. Train marketing and sales teams on the vocabulary that triggers device classification. Maintain a claims register that maps each claim to its regulatory justification. And when the boundary is genuinely unclear, seek a formal FDA determination rather than assuming the favourable interpretation.

Conclusion

The wellness-versus-device distinction is ultimately a question of intent, expressed through claims. The FDA's two-pronged test is straightforward in principle, but it demands discipline in execution. By auditing claims systematically, screening for disease language, and documenting your reasoning, you can confidently occupy the low-risk wellness space — or recognise early that you need to prepare for a device pathway.

Frequently Asked Questions

Q: Does the FDA approve general wellness products? A: No. General wellness products that meet the guidance criteria are not subject to FDA premarket review or approval. They remain subject to general requirements such as truthful advertising under FTC jurisdiction.

Q: Can a wellness product measure heart rate? A: Yes, if the claim is framed around general fitness or activity tracking. If the product claims to detect or monitor a cardiac condition such as atrial fibrillation, it becomes a medical device requiring clearance.

Q: Is there a character limit or word count rule for wellness claims? A: No. The FDA assesses the substance of claims, not their length. A single sentence can establish medical intended use.

Q: What if my product is used by both healthy people and patients? A: The relevant question is how you market it. If you target the general population and make no disease claims, wellness status may be available — but marketing to patient groups undermines that position.

Q: Does the wellness exemption apply to software and apps? A: Yes, in principle. The same two-pronged test applies to software. However, apps that interpret clinical data or recommend treatment fall under SaMD regulation.

Q: What is the penalty for misclassifying a device as wellness? A: Potential consequences include FDA warning letters, injunction, seizure of product, civil monetary penalties, and mandatory recalls. Marketing claims are the primary basis for enforcement.

Q: Where can I read the official FDA guidance? A: The FDA publishes General Wellness: Policy for Low Risk Devices in its guidance document database at fda.gov.

Disclaimer: This article is for informational purposes only and does not constitute legal or regulatory advice. Consult qualified regulatory professionals for guidance specific to your product.

Sources:

• U.S. Food and Drug Administration. General Wellness: Policy for Low Risk Devices — FDA.gov
• U.S. Food and Drug Administration. Is My Product a Medical Device? — FDA.gov
• U.S. Food and Drug Administration. Digital Health Center of Excellence — FDA.gov
• European Parliament and Council. Regulation (EU) 2017/745 on medical devices — EUR-Lex
• Federal Trade Commission. Health Products Compliance Guidance — ftc.gov